Evidence map›Paper›PMID 37602875›Full record

ArticleCNS neuroscience & therapeutics2023

Ofatumumab for the treatment of refractory anti-LGI1 encephalitis with long-term poor blood glucose control in type 1 diabetes.

Kaili Chen, Le Yang, Lei Xu, Yan Jiang, Jinting He

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in CNS neuroscience & therapeutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Efficacy of ofatumumab combined with corticosteroids in the treatment of autoimmune encephalitis: a 6-month cohort study.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Kaili ChenDepartment of Neurology, China-Japan Union Hospital of Jilin University, Changchun, China.ORCID 0009-0004-4727-8832
Le YangDepartment of Endocrinology, Jilin Province People's Hospital, Changchun, China.
Lei XuDepartment of Neurology, China-Japan Union Hospital of Jilin University, Changchun, China.
Yan JiangDepartment of Neurology, China-Japan Union Hospital of Jilin University, Changchun, China.
Jinting HeDepartment of Neurology, China-Japan Union Hospital of Jilin University, Changchun, China.ORCID 0000-0002-4930-2099
Union Hospital · CNPeople 's Hospital of Jilin Province · CN

Funding

Jilin Province Special Project for Health ResearchersJilin Provincial Finance Department in ChinaJilin Scientific and Technological Development Program in ChinaNational Natural Science Foundation of China
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes Mellitus, Type 1EncephalitisAntibodies, Monoclonal, HumanizedAutoantibodiesGlycemic ControlHumansProteinsAntibodies, Monoclonal, HumanizedAutoantibodiesofatumumabProteins

Identifiers

PMID37602875
PMCPMC10651958
OpenAlexW4386019689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.